Search

everythinglearnresearchcommunity

for

Search:↓

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

A woman in Sri Lanka was diagnosed with lupus after presenting with protein loss from the gut and other symptoms.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

Iranian veterans exposed to sulfur mustard suffer from long-term skin itching and eye damage, with some risk of skin cancer and ongoing management challenges.

Skin problems are common and early signs of Systemic Lupus Erythematosus, and certain immune system markers are important for diagnosis and treatment.

COVID-19 vaccines had more side effects and worse perception than flu vaccines in Korean lupus patients.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

Primary cicatricial alopecia causes permanent hair loss by destroying hair follicles, and its exact cause is unknown.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Dermoscopy is a useful tool for identifying features of skin conditions, but more research is needed to define its role in dermatology.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

The conclusion is that accurate diagnosis of different types of hair loss requires careful examination of tissue samples and understanding of clinical symptoms.

Different types of scarring alopecia may be stages of one disease, and accurate diagnosis is crucial to prevent permanent hair loss.

Pseudopelade of Brocq is hard to diagnose and treat, with limited effective options.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.